PCNA and glioblastoma: To interrogate the conclusion that SMAD2(+) identified the proliferation fraction of glioblastoma cells, we performed double-label immunohistochemistry for pSmad1 or pSmad2 and PCNA in human glioblastoma surgical specimens (n = 4, 15 HPF/specimen).